209 related articles for article (PubMed ID: 8634617)
1. Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study.
Wonderling D; McDermott C; Buxton M; Kinmonth AL; Pyke S; Thompson S; Wood D
BMJ; 1996 May; 312(7041):1269-73. PubMed ID: 8634617
[TBL] [Abstract][Full Text] [Related]
2. Costs and cost effectiveness of health checks conducted by nurses in primary care: the Oxcheck study.
Langham S; Thorogood M; Normand C; Muir J; Jones L; Fowler G
BMJ; 1996 May; 312(7041):1265-8. PubMed ID: 8634616
[TBL] [Abstract][Full Text] [Related]
3. What can be concluded from the Oxcheck and British family heart studies: commentary on cost effectiveness analyses.
Wonderling D; Langham S; Buxton M; Normand C; McDermott C
BMJ; 1996 May; 312(7041):1274-8. PubMed ID: 8634618
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care.
Turner DA; Paul S; Stone MA; Juarez-Garcia A; Squire I; Khunti K
Heart; 2008 Dec; 94(12):1601-6. PubMed ID: 18450843
[TBL] [Abstract][Full Text] [Related]
5. Strategies for reducing coronary risk factors in primary care: which is most cost effective?
Field K; Thorogood M; Silagy C; Normand C; O'Neill C; Muir J
BMJ; 1995 Apr; 310(6987):1109-12. PubMed ID: 7742678
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of nurse led secondary prevention clinics for coronary heart disease in primary care: follow up of a randomised controlled trial.
Raftery JP; Yao GL; Murchie P; Campbell NC; Ritchie LD
BMJ; 2005 Mar; 330(7493):707. PubMed ID: 15716289
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluation of a general practitioner with special interests led dermatology service in primary care.
Coast J; Noble S; Noble A; Horrocks S; Asim O; Peters TJ; Salisbury C
BMJ; 2005 Dec; 331(7530):1444-9. PubMed ID: 16339217
[TBL] [Abstract][Full Text] [Related]
8. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. Family Heart Study Group.
BMJ; 1994 Jan; 308(6924):313-20. PubMed ID: 8124121
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population.
Pharoah PD; Hollingworth W
BMJ; 1996 Jun; 312(7044):1443-8. PubMed ID: 8664620
[TBL] [Abstract][Full Text] [Related]
10. Mammography screening: an incremental cost effectiveness analysis of two view versus one view procedures in London.
Bryan S; Brown J; Warren R
J Epidemiol Community Health; 1995 Feb; 49(1):70-8. PubMed ID: 7707010
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study.
Boer R; de Koning H; Threlfall A; Warmerdam P; Street A; Friedman E; Woodman C
BMJ; 1998 Aug; 317(7155):376-9. PubMed ID: 9694752
[TBL] [Abstract][Full Text] [Related]
12. Cost analysis of nurse telephone consultation in out of hours primary care: evidence from a randomised controlled trial.
Lattimer V; Sassi F; George S; Moore M; Turnbull J; Mullee M; Smith H
BMJ; 2000 Apr; 320(7241):1053-7. PubMed ID: 10764368
[TBL] [Abstract][Full Text] [Related]
13. Healthcare and patient costs of a proactive chlamydia screening programme: the Chlamydia Screening Studies project.
Robinson S; Roberts T; Barton P; Bryan S; Macleod J; McCarthy A; Egger M; Sanford E; Low N;
Sex Transm Infect; 2007 Jul; 83(4):276-81. PubMed ID: 17229792
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of telephone or surgery asthma reviews: economic analysis of a randomised controlled trial.
Pinnock H; McKenzie L; Price D; Sheikh A
Br J Gen Pract; 2005 Feb; 55(511):119-24. PubMed ID: 15720933
[TBL] [Abstract][Full Text] [Related]
15. Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.
Mason JM; Moayyedi P; Young PJ; Duffett S; Crocombe W; Drummond MF; Axon AT
Int J Technol Assess Health Care; 1999; 15(4):649-60. PubMed ID: 10645106
[TBL] [Abstract][Full Text] [Related]
16. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
Fidan D; Unal B; Critchley J; Capewell S
QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875
[TBL] [Abstract][Full Text] [Related]
17. Controlled trial of pharmacist intervention in general practice: the effect on prescribing costs.
Rodgers S; Avery AJ; Meechan D; Briant S; Geraghty M; Doran K; Whynes DK
Br J Gen Pract; 1999 Sep; 49(446):717-20. PubMed ID: 10756613
[TBL] [Abstract][Full Text] [Related]
18. NHS Direct versus general practice based triage for same day appointments in primary care: cluster randomised controlled trial.
Richards DA; Godfrey L; Tawfik J; Ryan M; Meakins J; Dutton E; Miles J
BMJ; 2004 Oct; 329(7469):774. PubMed ID: 15377574
[TBL] [Abstract][Full Text] [Related]
19. Systematic care of diabetic patients in one general practice: how much does it cost?
Koperski M
Br J Gen Pract; 1992 Sep; 42(362):370-2. PubMed ID: 1457172
[TBL] [Abstract][Full Text] [Related]
20. A RCT of three training and support strategies to encourage implementation of screening and brief alcohol intervention by general practitioners.
Kaner EF; Lock CA; McAvoy BR; Heather N; Gilvarry E
Br J Gen Pract; 1999 Sep; 49(446):699-703. PubMed ID: 10756610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
